Elsevier

Bone

Volume 18, Issue 2, February 1996, Pages 191-196
Bone

Original article
Long-term effects of clodronate on growing rat bone

https://doi.org/10.1016/8756-3282(95)00439-4Get rights and content

Abstract

For evaluating the long-term effects of the bisphosphonate compound clodronate on the rat skeleton, 100 female rats were given subcutaneous injections of clodronate at doses of 0 (vehicle), 4 (low), or 12 (high) mg/kg per week, or 50 mg/kg every fourth week (cyclical). The treatment was started at 3 months of age and was continued for 6 months. The mechanical strength of bones was studied by torsion of the tibia, three-point bending of the femur, axial compression of the femoral neck, and compression of a lumbar vertebra. Quantitative histomorphometric variables were determined from distal femur and lumbar vertebra, and variables reflecting bone metabolism were measured in serum and urine. Bone mass, indicated by ash weight of the tibia, was increased with the low and high clodronate doses compared with the vehicle. The maximum load in vertebra compression was increased with the low dose of clodronate compared with the vehicle, whereas changes in other variables concerning bone strength were not significant. In bone histomorphometry, clodronate treatment induced more pronounced changes in cancellous bone volume in distal femur than in lumbar vertebra, the differences not being statistically significant between the groups at either site, however. The longitudinal growth rate of the femur, measured by double-fluorochrome labeling for 1 week at the end of the treatment period, was significantly decreased in the high-dose clodronate group compared with the other groups. Serum values for calcium, tartrate-resistant acid phosphatase, and alkaline phosphatase did not differ between the groups. However, serum osteocalcin was significantly lower in the high-dose group compared with the vehicle group. Urinary calcium, hydroxyproline, and hydroxylysylpyridinoline were decreased at all the clodronate doses administered. In conclusion, the beneficial effects of long-term clodronate treatment on bone mass and strength were observed at the lowest dose used. A high dose of clodronate decreased bone growth rate, which was, however, not reflected in the mechanical quality of bone.

References (40)

  • P. Ammann et al.

    IGF-1 and pamidronate increase bone mineral density in ovariectomized adult rats

    Am J Physiol

    (1993)
  • R. Balena et al.

    The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

    J Clin Invest

    (1993)
  • Chow, J.W.M., Badve, S. and Cambers, T.J. A comparison of microanammic basis for coupling between bone formation and...
  • N. Dalen et al.

    Bone mineral content and mechanical strength of the femoral neck

    Acta Orthop Scand

    (1976)
  • M.C. de Vemejoul et al.

    Different schedules of administration of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonateinduce different changes in pig bone remodelling

    Calcif Tissue Int

    (1987)
  • R.A. Evans et al.

    The effects of long-term low-dose diphosphonate treatment on rat bone

    Clin Orthop

    (1982)
  • H. Fleisch

    Bisphosphonates-History and experimental basis

    Bone

    (1987)
  • P. Geusens et al.

    Longitudinal effect of fludronate on bone mineral density, resonant frequency, and strength in monkeys

    J Bone Miner Res

    (1992)
  • M.D. Grynpas et al.

    Changes in bone mineralization, architecture and mechanical properties due to long-term (I year) administration of pamidronate (APD) to adult dogs

    Osteopor Int

    (1992)
  • J.A. Guy et al.

    Continuous alendronate treatment throughout growth, maturation and aging in the rat results in increases in bone mass and mechanical properties

    Calcif Tissue Int

    (1993)

    • Cited by (0)

    View full text
    Copyright © 1996 Published by Elsevier Inc.